SCHEMBL10071095

SCHEMBL10071095

C[C@@H](Cc1ccc(OCc2ccccc2)cc1)CN1CCC[C@H]1C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACE P12821 2/20 0.52
HRH3 Q9Y5N1 3/20 0.51
SPHK1 Q9NYA1 1/20 0.51
CD274 Q9NZQ7 2/20 0.49
LMNA P02545 1/20 0.49
GAA P10253 1/20 0.49
RAB9A P51151 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
MEN1 O00255 1/20 0.48
NPC1 O15118 1/20 0.48
ALDH1A1 P00352 1/20 0.48
TP53 P04637 1/20 0.48
ALOX15 P16050 1/20 0.48
KMT2A Q03164 1/20 0.48
LTA4H P09960 2/20 0.48
PDCD1 Q15116 1/20 0.47
KDM4E B2RXH2 1/20 0.47
MAOB P27338 2/20 0.47
POLB P06746 1/20 0.46
MAOA P21397 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10071091 0.88 ACE (0.57) ACEHRH3SPHK1LMNAGAA
SCHEMBL10083004 0.87 ACE (0.52) ACEHRH3SPHK1CD274LMNA
SCHEMBL10071089 0.82 F2 (0.46) ACE
SCHEMBL5732641 0.78 ACE (0.47) ACESPHK1SMN1; SMN2
SCHEMBL14973399 0.77 ACE (0.59) ACESPHK1LTA4HGYS1
SCHEMBL10906633 0.75 ACE (0.67) ACELMNASMN1; SMN2LTA4HGYS1
SCHEMBL10447086 0.74 F2 (0.62) ACELTA4H
SCHEMBL10447085 0.74 F2 (0.62) ACELTA4H
SCHEMBL10057899 0.74 DPP4 (0.56) ACESPHK1
SCHEMBL6508605 0.73 MAOB (0.65) SPHK1CD274PDCD1MAOBPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120045393-A1 LHRH-II PEPTIDE ANALOGS BRACCO IMAGING SPA (IT) 2012-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120045393-A1 LHRH-II PEPTIDE ANALOGS LHCGR, GNRHR, FSHR ACE 2838/4885HRH3 364/4885SPHK1 1176/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.